We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Raffles to Launch Second Hospital Project in China

By HospiMedica International staff writers
Posted on 09 May 2017
Raffles Medical Group, one of the leading integrated healthcare organizations in Asia, has announced that it is developing its second international tertiary hospital in Chongqing (China).

When completed, the international Raffles Hospital Chongqing will be able to serve local and expatriate patients in the western part of China, as well as foreign patients from Central Asian republics. More...
The new 700-bed capacity hospital and the soon to be completed 400-bed capacity Raffles Hospital Shanghai are expected to start operations at the end of 2018 with 200 private beds each. Raffles Medical clinics in Chongqing, Shanghai, Beijing, Nanjing, Tianjin, Dalian, and Shenzhen, which have access to the Raffles Medical network, will feed into the two new China hospitals.

Raffles Medical Group, which is based in Singapore, currently operates in 13 cities across Asia, and has announced plans for two new hospitals in Beijing and Shenzhen, and is considering a third. The medical group currently holds representative offices in Indonesia, Vietnam, Cambodia, Brunei, Bangladesh, and the Russian Far East, as well as business associates throughout the Asia Pacific region.

“We have done our market survey, and found that the top 10% of 33 million people in Chongqing can afford internationally priced health care,” said Loo Choon Yong, MD, executive chairman of Raffles Medical Group. “Together with the upcoming Shanghai hospital, we will be a major player in tertiary hospital services in China, where there is significant demand for good quality healthcare from locals and foreigners.”

The State Council of the People’s Republic of China (Beijing; www.gov.cn) announced in June 2015 that it will reduce bureaucratic red-tape for new facilities. Among other measures, private-capital-invested hospitals will be integrated into the medical insurance system, a move designed to encourage the development of new medical institutions. The State Council also stipulated that public health insurance will extend healthcare coverage to qualified private facilities, and will not be able to reject them for reasons other than their medical service abilities.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
IV Therapy Cart
Avalo I.V Therapy Cart
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.